Cargando…
Integrating Gene Correction in the Reprogramming and Transdifferentiation Processes: A One-Step Strategy to Overcome Stem Cell-Based Gene Therapy Limitations
The recent advent of induced pluripotent stem cells (iPSCs) and gene therapy tools has raised the possibility of autologous cell therapy for rare genetic diseases. However, cellular reprogramming is inefficient in certain diseases such as ataxia telangiectasia, Fanconi anemia, LIG4 syndrome, and fib...
Autores principales: | Lee, Seo-Young, Chung, Sun-Ku |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5198186/ https://www.ncbi.nlm.nih.gov/pubmed/28074097 http://dx.doi.org/10.1155/2016/2725670 |
Ejemplares similares
-
Concurrent progress of reprogramming and gene correction to overcome therapeutic limitation of mutant ALK2-iPSC
por: Kim, Bu-Yeo, et al.
Publicado: (2016) -
Editorial: Transdetermination, transdifferentiation, and reprogramming of cells: In vitro and in vivo strategies
por: Cieslar-Pobuda, Artur, et al.
Publicado: (2023) -
Cell Reprogramming, IPS Limitations, and Overcoming Strategies in Dental Bioengineering
por: Ibarretxe, Gaskon, et al.
Publicado: (2012) -
Reprogramming, oscillations and transdifferentiation in epigenetic landscapes
por: Kaity, Bivash, et al.
Publicado: (2018) -
Exploring the Mechanisms of Differentiation, Dedifferentiation, Reprogramming and Transdifferentiation
por: Xu, Li, et al.
Publicado: (2014)